Fragen? Antworten! Siehe auch: Alternativlos
The patents, held by VeriChip partner Receptors LLC, relate to biosensors that can detect the H1N1 and other viruses, and biological threats such as methicillin-resistant Staphylococcus aureus, VeriChip said in a statement.
Au weia. (Danke, Florian)